Navigation Links
Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
Date:7/11/2011

are driving the aggressive behavior of melanoma. Further, when they are expressed across other tumor types they may play a similar role. This is supported by the fact that when we analyzed human breast cancer samples, some of these proteins were also able to predict the prognosis for patients with these tumors."

Metamark has exclusively licensed a portfolio of technologies, including those described in this manuscript, from the Dana Farber Cancer Institute. Based on the results of the Cancer Cell study, Metamark is developing a novel test for determining the prognosis of early stage melanoma.

"The reported Cancer Cell findings are of great importance for Metamark and further our efforts to predict the prognosis of early stage cancers, including malignant melanoma," said Peter Blume-Jensen, M.D., Ph.D., Chief Scientific Officer of Metamark. "This research is a concrete example of the value provided through the functional identification of molecules that play a direct role in tumor aggressiveness and supports Metamark's founding principle that early stage tumors contain key molecular information about their progression propensity. Our next goal is to incorporate markers such as these into molecular tests that will enable the identification of patients at high risk for progression independent of traditional risk parameters, such as lymph node status and thickness of the primary lesions."

This Cancer Cell study can be found at the following URL: http://www.cell.com/cancer-cell/abstract/S1535-6108(11)00195-4

About Metamark Genetics, Inc.

Metamark is a privately held oncology company focused on the development of function-based prognostic assays for early staged cancers. The MetamarkDx™ Prognostic Assays under development are based on Metamark's proprietary Prognosis Determinants™, genes discovered through leading edge ca
'/>"/>

SOURCE Metamark Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Metamark Genetics Partners with Definiens on Tissue-Based Cancer Diagnostics
2. Signal Genetics and DiagnoCure Announce a US$13.3M Collaboration for the Commercialization of Previstage™ GCC Colorectal Cancer Staging Test
3. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
4. Viral Genetics Updates HIV/AIDS and Drug Resistant Cancer Research Programs
5. Signal Genetics Announces Commercialization Partnership with NeoGenomics Laboratories for Multiple Myeloma Gene Expression Test
6. USP Hospitales of Spain to Offer Interleukin Genetics Heart Health Test Throughout Its Hospital Network
7. Interleukin Genetics and Metagenics Initiate Research Collaboration
8. Technology Collaboration Between New England Biolabs and Sequenom Delivers First Product for Epigenetics
9. LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry
10. RainDance Technologies and Ambry Genetics Expand Collaboration to Address ADME Analysis
11. JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 The acute coronary syndrome (ACS) therapeutics ... hundreds of generics. While generic ACS drugs currently lead ... expected to increase to more than 60 percent of ... of novel pipeline products between 2015 and 2019. The ... terms of revenues, driven primarily by incidence rates of ...
(Date:9/1/2015)... DIEGO and BEDFORD, Mass. ... Robbins Arroyo LLP is investigating whether certain ... the Securities and Exchange Act of 1934.  ConforMIS is ... technology platform to develop, manufacture, and sell joint replacement ... each patient,s unique anatomy. View this press ...
(Date:9/1/2015)... Delaware , United States , ... or "Invion"), is pleased to announce that it has entered ... institutional investor in the United States ... A$1.001 million ("Placement") by the issue of 71,500,000 million fully-paid ... share. The Company has also agreed to ...
Breaking Medicine Technology:Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 2Branded Acute Coronary Syndrome Therapies to Grab Market Share from Generic Drugs Globally 3Robbins Arroyo LLP Is Investigating the Officers and Directors of ConforMIS, Inc. (CFMS) on Behalf of Shareholders 2Invion Announces Private Placement to US Institutional Investor 2Invion Announces Private Placement to US Institutional Investor 3
... Reportlinker.com announces that a new market ... Gout Therapeutics Market to ... Krystexxa, Uloric, Adenuric and Colcrys to Drive ... Gout Therapeutics Market to 2017- ...
... YORK, March 31, 2011 Reportlinker.com announces that a ... Medical Imaging Markets ... of this TriMark Publications report is to describe the ... medical imaging. Medical imaging can be categorized into nine ...
Cached Medicine Technology:Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 2Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 3Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 4Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 5Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 6Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 7Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 8Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 9Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 10Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 11Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market 12Reportlinker Adds Medical Imaging Markets 2Reportlinker Adds Medical Imaging Markets 3Reportlinker Adds Medical Imaging Markets 4Reportlinker Adds Medical Imaging Markets 5Reportlinker Adds Medical Imaging Markets 6Reportlinker Adds Medical Imaging Markets 7Reportlinker Adds Medical Imaging Markets 8Reportlinker Adds Medical Imaging Markets 9Reportlinker Adds Medical Imaging Markets 10Reportlinker Adds Medical Imaging Markets 11Reportlinker Adds Medical Imaging Markets 12Reportlinker Adds Medical Imaging Markets 13Reportlinker Adds Medical Imaging Markets 14Reportlinker Adds Medical Imaging Markets 15Reportlinker Adds Medical Imaging Markets 16Reportlinker Adds Medical Imaging Markets 17
(Date:9/2/2015)... ... September 02, 2015 , ... This Fall, as Ovarian ... Bright Pink, a national non-profit focused on the prevention and early detection of ... campaign to educate women to be breast and ovarian self-aware and celebrate positive, ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... Traveling to ... a wide array of magnificent flora and fauna. , Lifestyle Holidays Vacation ... well-preserved history. To help make travelers experience that much better, Lifestyle Holidays Vacation Club ...
(Date:9/1/2015)... Hills, CA (PRWEB) , ... September 01, 2015 ... ... International Business Times discusses the hundreds of thousands of plastic surgeries conducted each ... media and reality TV for the growing numbers. Beverly Hills-based plastic surgeon Payam ...
(Date:9/1/2015)... ... , ... September is National Prostate Cancer Awareness Month and Florida Hospital Zephyrhills ... year in the United States. , Prostate cancer is to men what breast cancer ... in 7 men. One new case occurs every 2.3 minutes and a man dies ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Capillus82™ has ... of androgenic alopecia in adults, announces Miami-based medical device manufacturer, Capillus, LLC. FDA ... demonstrating its safety when used at home to combat hair loss. , ...
Breaking Medicine News(10 mins):Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Capillus82™ Laser Therapy Cap Receives FDA Clearance for Treatment of Hair Loss 2
... staff members working in a hospital,s fast-paced emergency department ... involved in medication errors that harm patients, new Johns ... serious issues related to temporary nursing staff in particular ... of the health care workforce owing to the national ...
... SUNY Downstate Medical Center have received a $50,000 grant ... develop a diagnostic test for the folate receptor autoantibody. ... cerebral folate deficiency in infants and autism spectrum disorders. ... United States, neural tube defects result in the brain ...
... to make people "tear up," but a new study led by ... nasal spray containing an ingredient derived from hot chili peppers ( ... sinus inflammation. The study, which appears in the August ... compares the use of the Capsicum annum nasal spray ...
... (HealthDay News) -- Interbreeding between modern humans, Neanderthals and ... boost peoples, immune systems today, researchers report. Modern ... share a common African ancestor, the team of scientists ... Science . However, the groups diverged into separate, distinct ...
... hormone receptor guanylyl cyclase C (GCC) has been established ... evidence from Thomas Jefferson University suggests it ... pandemics: obesity. Reporting in the August 25 ... Scott Waldman, M.D., Ph.D., chairman of the ...
... , THURSDAY, Aug. 25 (HealthDay News) -- For kids, the end ... sleeping until noon: It also signals the beginning of brand new ... your child is a preschooler or a teen, some anxiety about ... is to know how to ease your children,s stress and manage ...
Cached Medicine News:Health News:Temporary ER staff poses increased safety risk to patients 2Health News:Temporary ER staff poses increased safety risk to patients 3Health News:Researchers developing new test to measure risk for birth defects and neuro-developmental disorders 2Health News:Thank Neanderthals for That Healthy Immune System, Scientists Say 2Health News:Could a tumor suppressor also fight obesity? 2Health News:Parents Can Ease Back-to-School Stress 2Health News:Parents Can Ease Back-to-School Stress 3
... VerdaSee Mobile Location-ID™ offers a for asset ... are attached to all the assets that will ... device, is equipped with a reader, antenna, and ... be as small as 10 inches x 6 ...
... provides hospitals with a suite ... all their supplies, drugs, assets, ... remove all manual compliance from ... accurately. iRIS, or Intelligent Radio-Frequency ...
Agility can provide tracking and management of surgical instruments, instrument trays and case carts to significantly enhance the current central sterile department flow by improving efficiency....
The WatchMate MR model displays multiple alarms locally without individual identification, but ID numbers and names can be displayed at a central station. Alarms may be cleared locally under password...
Medicine Products: